Top Markets
Coin of the day
Dong Sung Bio Pharm.Co.,Ltd. Dong Sung Bio Pharm.Co.,Ltd.

Dong Sung Bio Pharm.Co.,Ltd.

002210
Κατάταξη σε μετοχές #28327
Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations... Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations spanning pharmaceuticals, cosmetics, hair dye manufacturing, and photodynamic therapy. Its extensive product range includes a broad selection of over-the-counter (OTC) medications designed to treat a variety of conditions. These encompass liver ailments, menopausal symptoms, skin disorders, obesity, digestive and gum health issues, and hair loss. The company's OTC offerings also feature remedies for fever, pain, inflammation, respiratory illnesses, scar reduction, and sleep disturbances, along with antiviral, anti-diarrhea, anti-nausea, blood circulation enhancing, antifungal, and antihistamine drugs. Supplementary OTC products include keratin softeners, eye nutrition supplements, and essential vitamins. Furthermore, Dong Sung Bio Pharm produces ethical (prescription-only, or ETC) drugs. These target specific medical areas such as endocrine, gastrointestinal, circulatory, neuropsychological, and oncological conditions. Its ETC portfolio also contains analgesic and anti-inflammatory agents, dermato-urinary treatments, antiviral, antibiotic, antifungal, and antihistamine medications, as well as respiratory drugs, steroids, and ophthalmic drops. Beyond its pharmaceutical lines, the company offers a range of consumer health and personal care items. These include hair coloring products, functional health foods, medical devices, various daily necessities, muscle taping supplies, disinfectants, toothpastes, shampoos for anti-hair loss and hair growth, and sanitary pads. Dong Sung Bio Pharm.Co.,Ltd. was founded in 1957 and maintains its headquarters in Seoul, South Korea.
Τιμή μετοχής
$1.11
Κεφαλαιοποίηση
$27.12M
Αλλαγή (1 ημέρα)
0.00%
Αλλαγή (1 έτος)
57.93%
Χώρα
KR
Εμπόριο Dong Sung Bio Pharm.Co.,Ltd. (002210)

Κατηγορία

Έσοδα για την Dong Sung Bio Pharm.Co.,Ltd. (002210)
Έσοδα τον Mar 2026 TTM: $55.28M
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της Dong Sung Bio Pharm.Co.,Ltd., τα τρέχοντα έσοδα της εταιρείας (TTM) είναι $55.28M. Το 2023, η εταιρεία είχε έσοδα $68.44M μείωση σε σύγκριση με τα έσοδα του έτους 2022, τα οποία ήταν $73.96M. Τα έσοδα είναι το συνολικό ποσό που παράγει μια εταιρεία από τις πωλήσεις προϊόντων ή υπηρεσιών. Σε αντίθεση με τα κέρδη, δεν αφαιρούνται έξοδα.
Ιστορικό εσόδων για την Dong Sung Bio Pharm.Co.,Ltd. από 2007 έως 2026
Έσοδα στο τέλος κάθε έτους
Έτος Έσοδα Αλλαγή
2026 (TTM) $55.28M -8.11%
2024 $60.16M -12.09%
2023 $68.44M -7.47%
2022 $73.96M 4.17%
2021 $71.00M -12.21%
2020 $80.87M 7.92%
2019 $74.94M -9.21%
2018 $82.54M 6.78%
2017 $77.30M 16.92%
2016 $66.12M 4.07%
2015 $63.53M -4.97%
2014 $66.85M -6.37%
2013 $71.41M -10.13%
2012 $79.45M 17.40%
2011 $67.68M 5.52%
2010 $64.14M 8.31%
2009 $59.22M 22.81%
2008 $48.22M -25.17%
2007 $64.44M 0.00%
Έσοδα για παρόμοιες εταιρείες ή ανταγωνιστές